ClassID:

170674

G01N2333/96425 - CPC Classification

Classification description:

Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Hydrolases (3) acting on peptide bonds (3.4); Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals

Recent Application in this class:
#1
20250354993
2025-11-20

METHODS OF TREATING AND DIAGNOSING LUNG CANCER

#2
20250215476
2025-07-03

EX VIVO PROTEASE ACTIVITY DETECTION FOR HEPATOCELLULAR CARCINOMA

#3
20250115918
2025-04-10

Treatment Of Uveitis With Endoplasmic Reticulum Aminopeptidase 1 (ERAP1) Inhibitors

#4
20250003968
2025-01-02

ACTIVITY-BASED CELL SORTING

#5
20240384004
2024-11-21

Monoclonal Antibody Against Canine Fibroblast Activation Protein that Cross-Reacts with Mouse and Human Fibroblast Activation Protein (FAP)

#6
20240325460
2024-10-03

MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY

#7
20240272160
2024-08-15

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

#8
20240125800
2024-04-18

NANOSENSORS FOR RAPID IDENTIFICATION OF LUNG CONDITIONS

#9
20230333115
2023-10-19

KIT FOR DETECTING ANTI-PROTEASOME SUBUNIT ALPHA TYPE 1-IMMUNOGLOBULIN G (IgG) ANTIBODY

#10
20230310431
2023-10-05

COMPOSITION FOR PREVENTING OR TREATING LIVER FIBROSIS, CONTAINING TRIAZOLE DERIVATIVE AS ACTIVE INGREDIENT

#11
20230250434
2023-08-10

Treatment of uveitis with endoplasmic reticulum aminopeptidase 1 (ERAP1) inhibitors

#12
20220397566
2022-12-15

GAMMA-SECRETASE STABILIZING COMPOUND SCREENING ASSAY

#13
20220155305
2022-05-19

METHODS OF TREATING AND DIAGNOSING LUNG CANCER

#14
20210311059
2021-10-07

METHODS OF ISOLATING BARREL-LIKE PROTEASES AND IDENTIFYING PEPTIDES PROCESSED THEREBY

#15
20210177917
2021-06-17

MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY

#16
20210172952
2021-06-10

IMMUNO-BASED RETARGETED ENDOPEPTIDASE ACTIVITY ASSAYS

#17
20210147528
2021-05-20

Methods of binding amyloid beta protein having pyroglutamate at the third amino acid residue (3pE abeta) in vivo using anti-3pE abeta antibodies or antigen-binding fragments thereof

#18
20210140946
2021-05-13

SYNCYTIOTROPHOBLAST EXTRACELLULAR VESICLES AS BIOMARKER FOR GESTATIONAL DIABETES MELLITUS

#19
20210087294
2021-03-25

Monoclonal antibody against canine fibroblast activation protein that cross-reacts with mouse and human fibroblast activation protein (FAP)

#20
20200165328
2020-05-28

Methods of detecting pyroglutamate amyloid beta protein (3pE Aβ) using anti-3pE Aβ antibodies

#21
20190324041
2019-10-24

Immuno-based retargeted endopeptidase activity assays

#22
20190128873
2019-05-02

Methods to specifically profile protease activity at lymph nodes

#23
20190033312
2019-01-31

Methods of isolating barrel-like proteases and identifying peptides processed thereby

#24
20180267044
2018-09-20

Prostate cancer markers and uses thereof

#25
20180142011
2018-05-24

Antibodies to pyroglutamate amyloid-β and uses thereof

#26
20180017574
2018-01-18

Method for the early diagnosis of a pre-diabetic state and type 2 diabetes

#27
20170248602
2017-08-31

Immuno-based retargeted endopeptidase activity assays

#28
20170241986
2017-08-24

METHODS FOR IDENTIFYING COMPOUNDS THAT ALTER THE ACTIVITY OF IRHOM POLYPEPTIDES AND USE THEREOF

#29
20170212117
2017-07-27

Method and kit for detecting bacterial infection

#30
20170191988
2017-07-06

Compositions and methods for identifying protease inhibitors

#31
20170016915
2017-01-19

SCREENING TARGETS AND COMPOSITIONS AND METHODS FOR TREATMENT OF CILIOPATHY DISORDERS

#32
20150301050
2015-10-22

Immuno-based retargeted endopeptidase activity assays

#33
20150045245
2015-02-12

BIOMARKERS AND TEST PANELS USEFUL IN SYSTEMIC INFLAMMATORY CONDITIONS

#34
20140162286
2014-06-12

Method for the detection of enzymatic activity with magnetically functionalized substrates

#35
20130029362
2013-01-31

MARKERS AND ASSAYS FOR DETECTION OF NEUROTOXICITY

#36
20120214186
2012-08-23

METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta

#37
20120208209
2012-08-16

PCSK9 IMMUNOASSAY

#38
20110182815
2011-07-28

METHOD FOR THE DETECTION OF ENZYMATIC ACTIVITY WITH MAGNETICALLY FUNCTIONALIZED SUBSTRATES

#39
20110165577
2011-07-07

SELECTION OF COLORECTAL CANCER PATIENTS FOR NEO-ADJUVANT AND ADJUVENT SYSTEMIC ANTI-CANCER TREATMENT

#40
20110104171
2011-05-05

EphA4 Polypeptide Having a Novel Activity and Use Thereof

#41
20100285597
2010-11-11

DETECTION OF FRAGMENTS OF NECTIN-1 FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE

#42
20100233741
2010-09-16

Immuno-based retargeted endopeptidase activity assays

#43
20100221760
2010-09-02

METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING sAPPbeta

#44
20100093010
2010-04-15

Inhibitor for the formation of gamma-secretase complex

#45
20090325168
2009-12-31

HOMO-DOUBLY LABELED COMPOSITIONS FOR THE DETECTION OF ENZYME ACTIVITY IN BIOLOGICAL SAMPLES

#46
20090275049
2009-11-05

Processing of EphA4 polypeptide by γ-secretase activity

#47
20090275012
2009-11-05

Process for determining S-nitrosothiols in biological fluids

#48
20090162878
2009-06-25

METHODS AND COMPOSITIONS FOR DETECTING AND QUANTIFYING SAPPB

#49
20080299596
2008-12-04

Substrates and assays for beta-secretase activity

#50
20080213250
2008-09-04

Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases

#51
20080090260
2008-04-17

Substrates and Assays for Beta Secretase Activity

#52
20070161700
2007-07-12

Inhibitor for the formation of y-secretase complex

#53
20070155650
2007-07-05

Use of cathepsin z inhibitors for the treatment of rhuematoid arthritis and other autoimmune diseases

#54
20050287066
2005-12-29

Anti-rat angiotensin I-converting enzyme (ACE, CD143) monoclonal antibodies and uses thereof

#55
20050250154
2005-11-10

Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof

#56
20050249733
2005-11-10

Mammalian proteases; related reagents

#57
20050158766
2005-07-21

Homo-doubly labeled compositions for the detection of enzyme activity in biological samples

#58
20050158302
2005-07-21

Methods for diagnosing and treating autoimmune disease

#59
20050112696
2005-05-26

Compositions, methods and assays related to secretase cleavage specificity

#60
20050096564
2005-05-05

Method of distributing skin care products

#61
20050096457
2005-05-05

Substrates and assays for beta-secretase

#62
20050037432
2005-02-17

Novel biomarkers of aggrecanase activity